Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2024 Filed Feb 26, 2024 22:03 UTC |
GEMAYEL GEORGESDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 8,252 | $0.00 Strike: $27.94 | $0.00 |
DisclosureSEC source: 0001104659-24-027583 · tm247055-8_4seq1.xml · derivative · entry 2 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,252 Underlying: Common Stock · 8,252 shares Expires 2034-02-22 F1 · derivative.exercise_date: The option vests on February 22, 2025. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:02 UTC |
Barlow CarroleeDirector
|
GrantRestricted Stock Units · Derivative | 5,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027582 · tm247055-6_4seq1.xml · derivative · entry 3 Barlow Carrolee · CIK 0001745316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,369 Underlying: Common Stock · 5,369 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025. F3 · derivative.expiration_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:02 UTC |
Barlow CarroleeDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 8,252 | $0.00 Strike: $27.94 | $0.00 |
DisclosureSEC source: 0001104659-24-027582 · tm247055-6_4seq1.xml · derivative · entry 2 Barlow Carrolee · CIK 0001745316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,252 Underlying: Common Stock · 8,252 shares Expires 2034-02-22 F1 · derivative.exercise_date: The option vests on February 22, 2025 Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:02 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $27.94 | $0.00 |
DisclosureSEC source: 0001104659-24-027578 · tm247055-14_4seq1.xml · derivative · entry 5 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-02-22 F6 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 22, 2025. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:02 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
GrantRestricted Stock Unit · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027578 · tm247055-14_4seq1.xml · derivative · entry 4 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F5 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. F5 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:02 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Disposition to issuerRestricted Stock Unit · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027578 · tm247055-14_4seq1.xml · derivative · entry 3 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 750 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F4 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. F4 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:02 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Tax withholdingCommon Stock | 372 | $27.94 | $10,393.68 |
DisclosureSEC source: 0001104659-24-027578 · tm247055-14_4seq1.xml · nonDerivative · entry 2 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,958 F2 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:02 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027578 · tm247055-14_4seq1.xml · nonDerivative · entry 1 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,330 F1 · balance_after: Includes an aggregate of 415 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:01 UTC |
Sensenig BethanyDirector
|
GrantRestricted Stock Units · Derivative | 5,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027575 · tm247055-9_4seq1.xml · derivative · entry 2 Sensenig Bethany · CIK 0001899935 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,369 Underlying: Common Stock · 5,369 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025. F3 · derivative.expiration_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:01 UTC |
Sensenig BethanyDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 8,252 | $0.00 Strike: $27.94 | $0.00 |
DisclosureSEC source: 0001104659-24-027575 · tm247055-9_4seq1.xml · derivative · entry 1 Sensenig Bethany · CIK 0001899935 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,252 Underlying: Common Stock · 8,252 shares Expires 2034-02-22 F1 · derivative.exercise_date: The option vests on February 22, 2025. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:01 UTC |
Khattar Jack A.Director · President, CEO
|
GrantPerformance Share Unit · Derivative | 35,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027572 · tm247055-5_4seq1.xml · derivative · entry 4 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires not disclosed F2 · derivative.exercise_date: On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023. F2 · derivative.expiration_date: On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:01 UTC |
Khattar Jack A.Director · President, CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 322,000 | $0.00 Strike: $27.94 | $0.00 |
DisclosureSEC source: 0001104659-24-027572 · tm247055-5_4seq1.xml · derivative · entry 3 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 322,000 Underlying: Common Stock · 322,000 shares Expires 2034-02-22 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 22, 2025. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:00 UTC |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
Disposition to issuerRestricted Stock Units · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027564 · tm247055-2_4seq1.xml · derivative · entry 3 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 750 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. F3 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:00 UTC |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
Tax withholdingCommon Stock | 246 | $27.94 | $6,873.24 |
DisclosureSEC source: 0001104659-24-027564 · tm247055-2_4seq1.xml · nonDerivative · entry 2 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,168 F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:00 UTC |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-027564 · tm247055-2_4seq1.xml · nonDerivative · entry 1 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,414 Read SEC document |
| February 12, 2024 Filed Feb 22, 2024 22:28 UTC |
Khattar Jack A.Director · President, CEO
|
OtherCommon Stock | 16,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-026630 · tm247055-1_4seq1.xml · nonDerivative · entry 2 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By the KBT Trust Disclosed balance after: 1,022,450 F1 · price: The Reporting Person is filing this Form 4 to reflect the fact that 16,500 shares were transferred from the KBT Trust to the Reporting Person on February 12, 2024 without consideration and are now owned directly. Read SEC document |
| February 12, 2024 Filed Feb 22, 2024 22:28 UTC |
Khattar Jack A.Director · President, CEO
|
OtherCommon Stock | 16,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-026630 · tm247055-1_4seq1.xml · nonDerivative · entry 1 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 897,005 F1 · price: The Reporting Person is filing this Form 4 to reflect the fact that 16,500 shares were transferred from the KBT Trust to the Reporting Person on February 12, 2024 without consideration and are now owned directly. Read SEC document |
| January 10, 2024 Filed Jan 12, 2024 22:00 UTC |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $9.24 | $0.00 |
DisclosureSEC source: 0001104659-24-003741 · tm243247-1_4seq1.xml · derivative · entry 3 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires 2024-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023. F4 · derivative.exercise_date: The option vested in four equal annual installments beginning on January 21, 2015. Read SEC document |
| January 10, 2024 Filed Jan 12, 2024 22:00 UTC |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
SaleCommon Stock | 8,000 | $27.91 | $223,280.00 |
DisclosureSEC source: 0001104659-24-003741 · tm243247-1_4seq1.xml · nonDerivative · entry 2 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 85,664 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.69 to $28.22, inclusive. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| January 10, 2024 Filed Jan 12, 2024 22:00 UTC |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
Exercise / conversionCommon Stock | 8,000 | $9.24 | $73,920.00 |
DisclosureSEC source: 0001104659-24-003741 · tm243247-1_4seq1.xml · nonDerivative · entry 1 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 93,664 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023. F2 · balance_after: Includes an aggregate of 415 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| December 22, 2023 Filed Dec 26, 2023 22:01 UTC |
Rubin JonathanSr. VP, Chief Medical Officer
|
Exercise / conversionPerformance Share Unit · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-129243 · tm2333640-2_4seq1.xml · derivative · entry 3 Rubin Jonathan · CIK 0001836067 · Sr. VP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2022. F3 · derivative.exercise_date: On February 22, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022. F3 · derivative.expiration_date: On February 22, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022. Read SEC document |
| December 22, 2023 Filed Dec 26, 2023 22:01 UTC |
Rubin JonathanSr. VP, Chief Medical Officer
|
Tax withholdingCommon Stock | 204 | $27.66 | $5,642.64 |
DisclosureSEC source: 0001104659-23-129243 · tm2333640-2_4seq1.xml · nonDerivative · entry 2 Rubin Jonathan · CIK 0001836067 · Sr. VP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,243 F2 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. Read SEC document |
| December 22, 2023 Filed Dec 26, 2023 22:01 UTC |
Rubin JonathanSr. VP, Chief Medical Officer
|
Exercise / conversionCommon Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-129243 · tm2333640-2_4seq1.xml · nonDerivative · entry 1 Rubin Jonathan · CIK 0001836067 · Sr. VP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,447 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2022. Read SEC document |
| December 22, 2023 Filed Dec 26, 2023 22:00 UTC |
Khattar Jack A.Director · President, CEO
|
Exercise / conversionPerformance Share Unit · Derivative | 25,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-129241 · tm2333640-1_4seq1.xml · derivative · entry 4 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2022. F3 · derivative.exercise_date: On February 22, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022. F3 · derivative.expiration_date: On February 22, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022. Read SEC document |
| December 22, 2023 Filed Dec 26, 2023 22:00 UTC |
Khattar Jack A.Director · President, CEO
|
Tax withholdingCommon Stock | 11,958 | $27.66 | $330,758.28 |
DisclosureSEC source: 0001104659-23-129241 · tm2333640-1_4seq1.xml · nonDerivative · entry 2 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 880,505 F2 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. Read SEC document |
| December 22, 2023 Filed Dec 26, 2023 22:00 UTC |
Khattar Jack A.Director · President, CEO
|
Exercise / conversionCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-129241 · tm2333640-1_4seq1.xml · nonDerivative · entry 1 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 892,463 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2022. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 22:00 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
GrantPerformance Share Unit · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-126930 · tm2333121-1_4seq2.xml · derivative · entry 2 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600 Underlying: Common Stock · 600 shares Expires not disclosed F2 · derivative.exercise_date: On February 22, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022. F2 · derivative.expiration_date: On February 22, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 22:00 UTC |
Khattar Jack A.Director · President, CEO
|
GrantPerformance Share Unit · Derivative | 25,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-126933 · tm2333121-2_4seq2.xml · derivative · entry 3 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires not disclosed F1 · derivative.exercise_date: On February 22, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022. F1 · derivative.expiration_date: On February 22, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 17:00 UTC |
NEWHALL CHARLES W IIIDirector
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 7,457 | $0.00 Strike: $9.24 | $0.00 |
DisclosureSEC source: 0001104659-23-119962 · tm2331055-2_4seq1.xml · derivative · entry 3 NEWHALL CHARLES W III · CIK 0001005544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,457 shares Expires 2024-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 17:00 UTC |
NEWHALL CHARLES W IIIDirector
|
SaleCommon Stock | 2,500 | $28.01 | $70,025.00 |
DisclosureSEC source: 0001104659-23-119962 · tm2331055-2_4seq1.xml · nonDerivative · entry 2 NEWHALL CHARLES W III · CIK 0001005544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,089 F1 · shares: Represents the number of shares of common stock sold to cover the exercise price of the employee stock options. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 17:00 UTC |
NEWHALL CHARLES W IIIDirector
|
Exercise / conversionCommon Stock | 7,457 | $9.24 | $68,902.68 |
DisclosureSEC source: 0001104659-23-119962 · tm2331055-2_4seq1.xml · nonDerivative · entry 1 NEWHALL CHARLES W III · CIK 0001005544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,589 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 17:00 UTC |
Hudson Frederick M.Director
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 7,457 | $0.00 Strike: $9.24 | $0.00 |
DisclosureSEC source: 0001104659-23-119592 · tm2331055-1_4seq1.xml · derivative · entry 4 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,457 shares Expires 2024-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 17:00 UTC |
Hudson Frederick M.Director
|
SaleCommon Stock | 5,211 | $28.50 | $148,513.50 |
DisclosureSEC source: 0001104659-23-119592 · tm2331055-1_4seq1.xml · nonDerivative · entry 3 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,231 Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 17:00 UTC |
Hudson Frederick M.Director
|
SaleCommon Stock | 3,882 | $28.50 | $110,637.00 |
DisclosureSEC source: 0001104659-23-119592 · tm2331055-1_4seq1.xml · nonDerivative · entry 2 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,442 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.49 to $28.53, inclusive. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 17:00 UTC |
Hudson Frederick M.Director
|
Exercise / conversionCommon Stock | 7,457 | $9.24 | $68,902.68 |
DisclosureSEC source: 0001104659-23-119592 · tm2331055-1_4seq1.xml · nonDerivative · entry 1 Hudson Frederick M. · CIK 0001438462 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 22:00 UTC |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $9.24 | $0.00 |
DisclosureSEC source: 0001104659-23-119162 · tm2330879-1_4seq1.xml · derivative · entry 3 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2024-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in four equal annual installments beginning on January 21, 2015. Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 22:00 UTC |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
SaleCommon Stock | 1,110 | $28.13 | $31,224.30 |
DisclosureSEC source: 0001104659-23-119162 · tm2330879-1_4seq1.xml · nonDerivative · entry 2 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,681 F2 · shares: Represents the number of shares of common stock sold to cover the exercise price of the employee stock options. Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 22:00 UTC |
Mottola FrankSVP, Quality, GMP, Ops, IT
|
Exercise / conversionCommon Stock | 2,000 | $9.24 | $18,480.00 |
DisclosureSEC source: 0001104659-23-119162 · tm2330879-1_4seq1.xml · nonDerivative · entry 1 Mottola Frank · CIK 0001804567 · SVP, Quality, GMP, Ops, IT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,791 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes an aggregate of 343 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| October 13, 2023 Filed Oct 13, 2023 21:00 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
Exercise / conversionPerformance Share Unit · Derivative | 4,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-109142 · tm2328365-1_4seq1.xml · derivative · entry 3 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on February 23, 2023. F3 · derivative.exercise_date: On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023. F3 · derivative.expiration_date: On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023. Read SEC document |
| October 13, 2023 Filed Oct 13, 2023 21:00 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
Tax withholdingCommon Stock | 1,911 | $26.91 | $51,425.01 |
DisclosureSEC source: 0001104659-23-109142 · tm2328365-1_4seq1.xml · nonDerivative · entry 2 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,089 F2 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the PSU vesting. Read SEC document |
| October 13, 2023 Filed Oct 13, 2023 21:00 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
Exercise / conversionCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-109142 · tm2328365-1_4seq1.xml · nonDerivative · entry 1 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on February 23, 2023. Read SEC document |
| October 04, 2023 Filed Oct 6, 2023 21:02 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
GrantPerformance Share Unit · Derivative | 4,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-107539 · tm2327888-1_4seq1.xml · derivative · entry 2 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires not disclosed F2 · derivative.exercise_date: On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023. F2 · derivative.expiration_date: On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023. Read SEC document |
| September 07, 2023 Filed Sep 7, 2023 21:00 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Exercise / conversionPerformance Share Unit · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-098986 · tm2325321-3_4seq1.xml · derivative · entry 3 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of common stock received upon the settlement of certain performance share units granted to the Reporting person on February 23, 2023. F3 · derivative.exercise_date: On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023. F3 · derivative.expiration_date: On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023. Read SEC document |
| September 07, 2023 Filed Sep 7, 2023 21:00 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Tax withholdingCommon Stock | 1,182 | $32.10 | $37,942.20 |
DisclosureSEC source: 0001104659-23-098986 · tm2325321-3_4seq1.xml · nonDerivative · entry 2 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,165 F2 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the PSU vesting. Read SEC document |
| September 07, 2023 Filed Sep 7, 2023 21:00 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Exercise / conversionCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-098986 · tm2325321-3_4seq1.xml · nonDerivative · entry 1 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of common stock received upon the settlement of certain performance share units granted to the Reporting person on February 23, 2023. Read SEC document |
| September 07, 2023 Filed Sep 7, 2023 21:00 UTC |
Khattar Jack A.Director · President, CEO
|
Exercise / conversionPerformance Share Unit · Derivative | 35,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-098985 · tm2325321-2_4seq1.xml · derivative · entry 4 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on February 23, 2023. F3 · derivative.exercise_date: On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023. F3 · derivative.expiration_date: On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023. Read SEC document |
| September 07, 2023 Filed Sep 7, 2023 21:00 UTC |
Khattar Jack A.Director · President, CEO
|
Tax withholdingCommon Stock | 16,804 | $32.10 | $539,408.40 |
DisclosureSEC source: 0001104659-23-098985 · tm2325321-2_4seq1.xml · nonDerivative · entry 2 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 867,463 F2 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the PSU vesting. Read SEC document |
| September 07, 2023 Filed Sep 7, 2023 21:00 UTC |
Khattar Jack A.Director · President, CEO
|
Exercise / conversionCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-098985 · tm2325321-2_4seq1.xml · nonDerivative · entry 1 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 884,267 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on February 23, 2023. Read SEC document |
| August 30, 2023 Filed Sep 1, 2023 21:00 UTC |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 8,100 | $0.00 Strike: $23.99 | $0.00 |
DisclosureSEC source: 0001104659-23-097813 · tm2325321-1_4seq1.xml · derivative · entry 3 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,900 Underlying: Common Stock · 8,100 shares Expires 2030-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 21, 2021. Read SEC document |
| August 30, 2023 Filed Sep 1, 2023 21:00 UTC |
Martin Tami TillotsonSr. V.P., Regulatory Affairs
|
SaleCommon Stock | 8,100 | $32.00 | $259,200.00 |
DisclosureSEC source: 0001104659-23-097813 · tm2325321-1_4seq1.xml · nonDerivative · entry 2 Martin Tami Tillotson · CIK 0001539494 · Sr. V.P., Regulatory Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,249 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.01, inclusive. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.